secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2023-04-04T23:59:59+00:00
Accession:  0001193125-23-090316
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences COO Mark De Rosch resigns effective April 30, 2023
-------------------------------------------------------------------

- COO Mark De Rosch resigns, effective April 30, 2023.
- De Rosch to provide transition services for 30 days, extendable by another 30 days at Company's option.
- No successor named as of filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312523090316/0001193125-23-090316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312523090316/d465749d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-090316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer